准内分泌体:一种新的方法来管理炎症性肠病中的肠外并发症
Dinesh Thapa1, Anjali Ghimire1, Leon N Warne1,2
1Curtin Medical Research Institute, Curtin Medical School, Curtin University, Perth, WA 6102, Australia.
Pharmaceuticals (Basel, Switzerland)
|April 26, 2025
概括
调节内分泌基因组 (eCBome) 为炎症性肠病 (IBD) 提供了一种新的治疗策略. 针对eCBome解决了肠道炎症和全身肠外表现 (EIMs).
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 炎症性肠病 (IBD) 是一种慢性疾病,导致胃肠炎症和全身性肠外表现 (EIM).
- 目前的疗法往往无法解决EIM,突出显示了对新型治疗策略的需求.
- 免疫,肠道和神经系统之间的相互作用在IBD病变发生过程中至关重要.
研究的目的:
- 探索内可纳维因组 (eCBome) 在炎症性肠病 (IBD) 和其肠外表现 (EIMs) 中的作用.
- 确定eCBome调制作为IBD治疗策略的潜力.
主要方法:
- 在主要的科学数据库 (PubMed,Scopus,Web of Science,Science Direct,Google Scholar) 中进行了全面的文献搜索.
- 关键词包括"大麻素"",内分泌系统"",内分泌组"",炎症性肠病"和"肠外表现".
- 分析了同行评审的原始研究和评论文章.
主要成果:
- 内分泌大麻素体 (eCBome) 是一个由脂质媒介,受体和酶组成的网络,在免疫反应调节,肠道屏障完整性和全身炎症方面发挥着关键作用.
- 准eCBome已经显示出改善肠道炎症的潜力.
- eCBome调制可以减轻代谢,神经和肠外并发症,如关节炎,肝功能障碍和与IBD相关的皮肤病.
结论:
- 对内分泌瘤组 (eCBome) 的调节为炎症性肠病 (IBD) 的综合管理提供了一种有前途的方法.
- 针对eCBome可以解决局部肠道炎症和全身肠外表现 (EIMs).
- 需要进一步的机制研究来开发利用eCBome用于IBD治疗的有针对性的干预措施.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
80
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
80
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
97
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
97
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
86
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
86
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
236
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
236
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
101
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
101
Inflammatory Bowel Disease II: Crohn's Disease
127
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
127


